ProfileGDS5678 / 1420988_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 60% 60% 60% 60% 60% 61% 58% 60% 60% 60% 60% 60% 59% 60% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.6141660
GSM967853U87-EV human glioblastoma xenograft - Control 23.5867360
GSM967854U87-EV human glioblastoma xenograft - Control 33.5901760
GSM967855U87-EV human glioblastoma xenograft - Control 43.5526160
GSM967856U87-EV human glioblastoma xenograft - Control 53.538460
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.7182861
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6044358
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.5671860
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.5601860
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.579760
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.5718260
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.5615460
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5779959
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5797660